Shukra Pharmaceuticals adopts FY26 financials, declares dividend at 33rd AGM
- Shukra Pharmaceuticals held its 33rd AGM virtually on September 28, 2026
- Members adopted audited financial statements for FY26 and declared a final dividend
- Sanskruti Patel was re-appointed as Director (Executive) retiring by rotation
- Dinesh Chauhan's appointment as Additional Independent Director was regularized
- No shareholder queries were raised during the meeting proceedings
*this image is generated using AI for illustrative purposes only.
Shukra Pharmaceuticals Limited concluded its 33rd Annual General Meeting (AGM) on September 28, 2026, through video conferencing. The meeting focused on the adoption of audited financial statements for the fiscal year ended March 31, 2026, and the declaration of a final dividend for FY26.
The proceedings were chaired by Dhravin Shah, Executive Director, who was authorized by promoter Parshva Texchem India Private Limited. The meeting commenced at 12:00 pm and concluded at 12:24 pm. No shareholders raised any queries during the session.
Resolutions Passed
The members transacted the following items of ordinary and special business as outlined in the notice:
| Item | Particulars | Resolution Type |
|---|---|---|
| 1 | Adoption of audited financial statements for FY26 and reports | Ordinary |
| 2 | Declaration of final dividend for FY26 | Ordinary |
| 3 | Re-appointment of Sanskruti Patel as Director (Executive) | Ordinary |
| 4 | Regularization of Dinesh Chauhan as Additional Independent Director | Special |
Procedural Details
The Company Secretary confirmed that the requisite quorum was present. Voting was conducted electronically via National Securities Depository Limited (NSDL) services. Remote e-voting remained open from September 25, 2026, to September 27, 2026. Members present at the virtual meeting also had the option to vote during the session and for 15 minutes thereafter.
Rupal Patel, a practicing company secretary, served as the scrutinizer to ensure a fair and transparent voting process. The results of the voting are scheduled to be announced within 48 hours of the meeting's conclusion and will be displayed on the company website and stock exchange platforms.
Historical Stock Returns for Shukra Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.46% | +7.46% | +36.34% | +45.10% | +45.10% | +45.10% |
What specific dividend payout ratio was declared for FY26, and how does it compare to Shukra Pharmaceuticals' historical trends?
How might the regularization of Dinesh Chauhan as an Independent Director influence the company's future governance standards and strategic decision-making?
What are the projected revenue and profit growth targets outlined in the FY26 financial statements that were adopted during the meeting?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
